Lucas Buchanan Joins ONWARD Medical's Board of Directors
ONWARD Medical N.V., a leader in neurotechnology innovation, proudly announces the recent addition of Lucas Buchanan to its Board of Directors, an appointment that signifies a valuable step forward for the company. Buchanan, who is recognized for his significant contributions in the medical device sector, previously held the roles of Chief Financial Officer (CFO) and Chief Operating Officer (COO) at Silk Road Medical, where he adeptly navigated the company through its growth phase, leading to a successful acquisition by Boston Scientific.
Background of Lucas Buchanan
Buchanan is no stranger to the world of venture capital and medical technology. Prior to his time at Silk Road Medical, he was deeply immersed in the venture capital landscape with The Vertical Group, gaining a wealth of experience that he now brings to ONWARD Medical. Throughout his impressive career, he has taken on numerous roles as an investor, advisor, and board member for various cutting-edge medical device companies and healthcare investment funds.
Professional Accomplishments
With over 25 years of rich experience in commercialization, operations, business development, investing, and finance, Buchanan's expertise is unparalleled. His leadership at Silk Road Medical was instrumental in guiding the company from its inception to its initial public offering (IPO) in 2019, culminating in its acquisition by Boston Scientific. His diverse background also includes tenures at notable firms such as Medtronic and Ernst & Young, showcasing his capability in driving success in challenging environments.
ONWARD Medical's Vision
As a pioneering neurotechnology company, ONWARD Medical focuses on developing advanced therapies to restore movement, function, and independence for individuals affected by spinal cord injuries and other movement disabilities. The company's innovative approach is anchored in over ten years of dedicated scientific research and development, particularly through its groundbreaking ARC Therapy, which has been awarded multiple Breakthrough Device Designations by the FDA.
The Future with Buchanan
ONWARD Medical's CEO, Dave Marver, expressed enthusiasm about Buchanan's appointment, praising his unique blend of operational skills and strategic vision. “Lucas’s experience as both an operator and investor positions him perfectly to contribute as we continue to expand our efforts to enhance user lives worldwide,” said Marver. Buchanan echoed similar sentiments, emphasizing the company's inspiring mission to deliver hope and transformative technology to individuals facing mobility challenges.
Company's Innovative Approach
The company has made significant strides in developing the ARC-EX System, currently clearing it for commercial sale in the U.S. Moreover, ONWARD is actively researching a next-generation investigational implantable system known as ARC-IM, which may incorporate advanced brain-computer interface technology. Such innovations promise to propel ONWARD into a new era of medical technology, potentially revolutionizing the way movement is restored to those affected by spinal impairments.
Global Reach and Commitment
Headquartered in the Netherlands, ONWARD Medical operates in multiple regions with its Science and Engineering Center situated in Switzerland and an office in Boston, Massachusetts. This global presence reinforces the company's commitment to fostering relationships with healthcare providers and researchers worldwide, all aimed at accelerating breakthroughs in the field.
Get Involved with ONWARD Medical
Those interested in learning more about ONWARD Medical's initiatives to partner with the spinal cord injury community can easily engage with the company by visiting their official website. The company encourages individuals to stay updated on their technologies, research programs, and therapy availability.
Frequently Asked Questions
1. Who is Lucas Buchanan?
Lucas Buchanan is the newly appointed non-executive member of the Board at ONWARD Medical, known for his leadership roles in medical technology.
2. What experience does Buchanan bring to ONWARD Medical?
Buchanan has over 25 years in the medical device sector, with significant leadership experience at Silk Road Medical and venture capital roles.
3. What is ONWARD Medical's primary focus?
ONWARD Medical focuses on pioneering therapies that restore movement and independence for individuals with spinal cord injuries and disabilities.
4. What notable technology has ONWARD developed?
ONWARD's ARC Therapy has gained recognition, including multiple Breakthrough Device Designations from the FDA.
5. How can I learn more about ONWARD Medical?
You can stay informed about ONWARD Medical's initiatives and technology advancements by visiting their official website.
